Search

Novocure Ltd

Cerrado

SectorSanidad

17.85 1.83

Resumen

Variación precio

24h

Actual

Mínimo

17.78

Máximo

18.01

Métricas clave

By Trading Economics

Ingresos

55M

-16M

Ventas

9.5M

184M

BPA

-0.13

Margen de beneficios

-8.529

Empleados

1,605

EBITDA

53M

-11M

Recomendaciones

By TipRanks

Recomendaciones

Comprar

Estimación a 12 Meses

+64.44% upside

Dividendos

By Acuity

Próximas Ganancias

29 oct 2026

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

209M

2.1B

Apertura anterior

16.02

Cierre anterior

17.85

Noticias sobre sentimiento de mercado

By Acuity

55%

45%

254 / 339 Clasificación en Healthcare

Novocure Ltd Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

2 sept 2026, 20:08 UTC

News

Novocure Ltd is trading higher as it prepares for two investor events, including chats at the Wells Fargo and Morgan Stanley healthcare conferences.

1 sept 2026, 19:11 UTC

News

Novocure Ltd shares are lower following a data breach affecting over 1,400 U.S. records, disclosed in a regulatory filing earlier today.

28 ago 2026, 20:07 UTC

Novocure Ltd. shares are lower today, pulled back from earlier gains amid rising U.S. Treasury yields impacting broader equity markets.

27 ago 2026, 22:01 UTC

Novocure Ltd. shares are lower in after-market hours, reversing a three-session upward trend and moving below the 20-day moving average.

26 ago 2026, 20:08 UTC

Novocure Ltd's shares are higher today, continuing an upward trend. The stock is trading above its 20-day moving average and near its one-month range high.

25 ago 2026, 20:07 UTC

Novocure Ltd shares are higher today, reversing three days of declines. Easing Treasury yields and lower oil prices have supported overall market sentiment.

24 ago 2026, 21:01 UTC

Novocure Ltd. shares are higher in after-market hours, continuing a positive move since Monday's close and trading above the 20-day moving average.

21 ago 2026, 23:41 UTC

In after-market trading, Novocure Ltd shares moved higher, reaching the upper end of their one-month trading range, 5.40% above the 20-day moving average.

20 ago 2026, 19:16 UTC

Novocure shares are lower today, having reached a session low earlier. No specific company news was identified to explain the decline.

19 ago 2026, 23:11 UTC

Novocure Ltd shares closed higher in after-market trading, recovering from earlier lows and finishing above their 20-day moving average. No specific news was identified.

17 ago 2026, 19:56 UTC

Novocure Ltd. shares are trading higher, rebounding from recent declines and remaining above the 20-day moving average, indicating a shift in momentum.

15 ago 2026, 00:01 UTC

Novocure Ltd. shares are higher in after-market trading, showing notable strength since Friday's close and currently above the 20-day moving average.

14 ago 2026, 23:21 UTC

Novocure Ltd shares are higher in after-market trading, reversing a three-session decline. No specific company news was identified to explain this movement.

13 ago 2026, 21:01 UTC

Novocure Ltd. shares are lower in after-market trading, reflecting a shift in sentiment despite being above the 20-day moving average.

12 ago 2026, 19:41 UTC

Novocure Ltd. shares are lower today, reversing a trend of higher daily closes since Tuesday. Earlier in the session, the stock rebounded from a session high.

11 ago 2026, 20:06 UTC

Novocure Ltd's shares are advancing, remaining above the 20-day moving average amid strong momentum. No specific company news has been identified for the price movement.

10 ago 2026, 21:01 UTC

Novocure Ltd shares are higher in after-market trading, supported by strong performance above the 20-day moving average and within the one-month trading range.

8 ago 2026, 00:01 UTC

Novocure Ltd. shares were roughly flat in after-market hours. The stock is near the lower end of its one-month range, despite being above its 20-day average.

7 ago 2026, 23:11 UTC

Novocure Ltd. shares are lower in after-market trading, reflecting a decline since Friday's close and remaining near the lower end of their one-month range.

6 ago 2026, 19:36 UTC

Novocure Ltd. shares are trading lower, reaching a session low and remaining below the 20-day moving average during Thursday's trading session.

5 ago 2026, 19:56 UTC

Novocure Ltd. shares are lower today, trading below their 20-day moving average and near the lower end of their one-month range.

4 ago 2026, 21:02 UTC

Novocure Ltd. shares are lower in after-market trading, continuing a decline since Tuesday's close amid broader market volatility and fluctuating crude oil prices.

3 ago 2026, 20:06 UTC

Novocure Ltd. shares are higher today, reflecting broader market gains amid positive investor sentiment and declines in oil prices.

31 jul 2026, 19:46 UTC

Novocure Ltd. shares are lower today, retracing from earlier session highs amid rising bond yields and ongoing inflation concerns. The stock remains below its 20-day moving average.

30 jul 2026, 19:39 UTC

Novocure Ltd shares are higher today, recovering from an early dip. The stock remains below its 20-day moving average amid a trend of lower closes.

29 jul 2026, 18:55 UTC

Novocure Ltd's shares are declining today, reversing from a recent trend of higher daily closes. Earlier in the session, the stock briefly rebounded.

28 jul 2026, 23:31 UTC

Novocure Ltd. shares are lower in after-market hours, continuing a decline over the past four sessions and trading below the 20-day moving average.

27 jul 2026, 19:06 UTC

Novocure Ltd. shares are lower today amid a broader market decline influenced by a significant drop in crude oil prices.

24 jul 2026, 19:41 UTC

News
Social Media

Novocure Ltd's stock is lower following its Q2 earnings report, despite a narrower loss and revenue beat. Analysts lowered price targets amid ongoing investor concerns.

22 jul 2026, 20:04 UTC

Shares of Novocure Ltd. are lower today, continuing a decline since Tuesday's close amid broader market uncertainty ahead of the Federal Reserve meeting.

Comparación entre iguales

Cambio de precio

Novocure Ltd previsión

Precio Objetivo

By TipRanks

64.44% repunte

Estimación a 12 Meses

Media 29.5 USD  64.44%

Máximo 52 USD

Mínimo 17 USD

De acuerdo con 4 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Novocure Ltd Dist en los últimos 3 meses.

Consenso

By TipRanks

Comprar

4 ratings

2

Comprar

2

Mantener

0

Vender

Sentimiento

By Acuity

254 / 339 Clasificación en Sanidad

Noticias sobre sentimiento de mercado

Coyuntura bajista

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Por encima de la media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Novocure Ltd

NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Germany, Japan, Greater China, and internationally. The company's TTFields devices include Optune Gio and Optune Lua. It also has ongoing clinical trials investigating TTFields in brain metastases, gastric cancer, glioblastoma, liver cancer, non-small cell lung cancer, pancreatic cancer, and ovarian cancer. NovoCure Limited was incorporated in 2000 and is headquartered in Baar, Switzerland.
help-icon Live chat